BMRN EBITDA | BIOMARIN PHARMACEUTICAL INC

BIOMARIN PHARMACEUTICAL INC (BMRN) EBITDA

2026-06-30: Basis Reported; EBITDA $208.56M*; Operating income $110.92M; Depreciation and amortization $97.64M*.
2026-03-31: Basis Reported; EBITDA $146.05M; Operating income (m); Depreciation and amortization (m).
2025-12-31: Basis Reported; EBITDA -$24.17M; Operating income (m); Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA -$28.20M*; Operating income -$46.69M; Depreciation and amortization $18.49M*.

Complete source-backed ebitda history.

Available history: 2013-12-31 to 2026-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	$208.56M*	$110.92M	$97.64M*	$989.71M	21.07%*	$28.82M*	$168.11M*	(m)	$206.95M	$395.55M	$16.62M
2026-03-31	Reported	$146.05M	(m)	(m)	(m)	19.06%	$20.92M	$220.65M	(m)	$178.80M	$258.29M	$35.68M
2025-12-31	Reported	-$24.17M	(m)	(m)	(m)	-2.76%	(m)	(m)	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$28.20M*	-$46.69M	$18.49M*	$776.13M	-3.63%*	$28.45M*	$368.69M*	(m)	$409.48M	$268.42M	$4.42M
2025-06-30	Reported	$295.45M*	$276.89M	$18.56M*	$825.41M	35.79%*	$17.10M*	$185.27M*	(m)	$161.31M	$232.28M	$57.34M
2025-03-31	Reported	$245.96M	(m)	(m)	(m)	33.01%	$16.77M	$174.39M	(m)	$158.73M	$206.12M	$52.40M
2024-12-31	Reported	$185.01M	(m)	(m)	(m)	24.76%	(m)	(m)	(m)	(m)	(m)	(m)
2024-09-30	Reported	$132.90M*	$113.89M	$19.01M*	$745.74M	17.82%*	$18.46M*	$221.48M*	(m)	$184.90M	$253.48M	$28.36M
2024-06-30	Reported	$146.91M*	$120.45M	$26.46M*	$712.03M	20.63%*	$21.33M*	$118.76M*	(m)	$183.79M	$263.03M	$24.96M
2024-03-31	Reported	$115.81M	(m)	(m)	(m)	17.85%	$26.10M	$46.97M	(m)	$204.99M	$225.91M	$16.89M
2023-12-31	Reported	$54.14M	(m)	(m)	(m)	8.38%	(m)	(m)	(m)	(m)	(m)	(m)
2023-09-30	Reported	$56.21M*	$30.52M	$25.68M*	$581.33M	9.67%*	$21.73M*	$135.65M*	(m)	$191.31M	$215.77M	$1.29M
2023-06-30	Reported	$90.98M*	$65.57M	$25.42M*	$595.27M	15.28%*	$21.58M*	$70.06M*	(m)	$177.36M	$206.10M	$14.77M
2023-03-31	Reported	$88.83M	(m)	(m)	(m)	14.89%	$24.46M	-$73.93M	(m)	$171.85M	$211.02M	$5.91M
2022-12-31	Reported	$11.47M	(m)	(m)	(m)	2.13%	(m)	(m)	(m)	(m)	(m)	(m)
2022-09-30	Reported	$22.39M*	-$2.42M	$24.80M*	$505.34M	4.43%*	$29.30M*	$158.32M*	(m)	$157.83M	$216.82M	$4.75M
2022-06-30	Reported	$64.42M*	$39.15M	$25.27M*	$533.80M	12.07%*	$27.15M*	$56.23M*	(m)	$158.19M	$196.84M	$7.19M
2022-03-31	Reported	$164.67M	(m)	(m)	(m)	31.71%	$28.82M	-$45.43M	(m)	$160.84M	$194.62M	$13.39M
2021-12-31	Reported	-$39.89M	(m)	(m)	(m)	-8.87%	(m)	(m)	(m)	(m)	(m)	(m)
2021-09-30	Reported	-$26.38M*	-$53.22M	$26.84M*	$408.74M	-6.45%*	$18.73M*	$97.06M*	(m)	$157.87M	$183.33M	-$9.67M
2021-06-30	Reported	$38.90M*	$11.67M	$27.23M*	$501.69M	7.75%*	$22.60M*	$82.78M*	(m)	$161.11M	$184.16M	$1.22M
2021-03-31	Reported	$53.07M	(m)	(m)	(m)	10.92%	$25.51M	$113.51M	(m)	$148.72M	$174.32M	$5.86M
2020-12-31	Reported	-$24.16M	(m)	(m)	(m)	-5.34%	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$29.31M*	-$55.94M	$26.63M*	$476.78M	-6.15%*	$16.57M*	$86.21M*	(m)	$147.05M	$179.45M	-$846.02M
2020-06-30	Reported	-$15.73M*	-$40.95M	$25.22M*	$429.49M	-3.66%*	$26.16M*	$27.74M*	(m)	$182.14M	$175.41M	-$13.09M
2020-03-31	Reported	$130.93M	(m)	(m)	(m)	26.08%	$40.55M	-$15.19M	(m)	$142.26M	$187.29M	$19.97M
2019-12-31	Reported	$16.63M	(m)	(m)	(m)	3.66%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	$34.75M*	$4.01M	$30.74M*	$461.10M	7.54%*	$32.85M*	$70.13M*	(m)	$172.96M	$170.11M	-$45.21M
2019-06-30	Reported	-$15.01M*	-$41.35M	$26.34M*	$387.76M	-3.87%*	$32.63M*	-$24.34M*	(m)	$185.64M	$160.75M	-$4.46M
2019-03-31	Reported	-$31.52M	(m)	(m)	(m)	-7.87%	$28.76M	-$54.87M	(m)	$183.59M	$162.16M	$3.52M
2018-12-31	Reported	-$13.43M	(m)	(m)	(m)	-3.80%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	$10.60M*	-$15.74M	$26.34M*	$391.71M	2.71%*	$49.86M*	$47.20M*	(m)	$161.41M	$148.57M	-$6.79M
2018-06-30	Reported	-$4.29M*	-$25.26M	$20.98M*	$372.85M	-1.15%*	$22.52M*	-$33.86M*	(m)	$175.58M	$153.28M	-$12.38M
2018-03-31	Reported	-$20.74M	(m)	(m)	(m)	-5.55%	$30.16M	-$42.51M	(m)	$183.95M	$138.34M	-$6.66M
2017-12-31	Reported	$86.71M	(m)	(m)	(m)	24.20%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	$6.97M*	-$13.73M	$20.70M*	$334.15M	2.09%*	$42.48M*	$38.29M*	(m)	$154.10M	$130.53M	-$8.09M
2017-06-30	Reported	-$19.73M*	-$38.81M	$19.09M*	$317.45M	-6.21%*	$47.76M*	(m)	(m)	$143.04M	$143.50M	-$8.71M
2017-03-31	Reported	-$796,000.00	(m)	(m)	(m)	-0.26%	$69.09M	(m)	(m)	$145.00M	$120.02M	-$8.02M
2016-12-31	Reported	-$69.51M	(m)	(m)	(m)	-23.16%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	-$30.66M*	-$60.09M	$29.42M*	(m)	(m)	$26.10M*	(m)	(m)	$160.83M	$118.76M	-$29.39M
2016-06-30	Reported	-$544.15M*	-$572.81M	$28.66M*	(m)	(m)	$25.51M*	(m)	(m)	$167.04M	$109.58M	-$163.93M
2016-03-31	Reported	-$62.19M	(m)	(m)	(m)	-26.27%	$45.20M	(m)	(m)	$158.79M	$105.30M	-$6.08M
2015-12-31	Reported	$114.21M	(m)	(m)	(m)	50.10%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$69.83M*	-$81.87M	$12.04M*	(m)	(m)	$44.56M*	(m)	(m)	$158.71M	$94.04M	$483.00K
2015-06-30	Reported	-$52.84M*	-$64.29M	$11.45M*	(m)	(m)	$35.46M*	(m)	(m)	$157.90M	$101.51M	-$554.00K
2015-03-31	Reported	-$55.04M	(m)	(m)	(m)	-27.13%	$43.83M	(m)	(m)	$142.07M	$92.81M	-$7.20M
2014-12-31	Reported	-$52.79M	(m)	(m)	(m)	-22.95%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	$25.43M*	$11.20M	$14.22M*	(m)	(m)	$25.17M*	(m)	(m)	$125.69M	$74.60M	-$4.22M
2014-06-30	Reported	(m)	-$18.88M	(m)	(m)	(m)	$20.00M	(m)	(m)	$107.70M	$68.09M	$5.77M
2014-03-31	Reported	(m)	-$26.46M	(m)	(m)	(m)	$23.61M	-$26.87M	(m)	$86.17M	$60.07M	$3.49M
2013-09-30	Reported	(m)	-$50.72M	(m)	(m)	(m)	$13.20M*	-$9.49M*	(m)	$88.06M	$61.84M	$704.00K
2013-06-30	Reported	(m)	-$20.05M	(m)	(m)	(m)	$10.41M*	-$6.82M*	(m)	$85.66M	$50.66M	$1.24M
2013-03-31	Reported	(m)	-$32.92M	(m)	(m)	(m)	$11.83M	-$32.03M	(m)	$83.74M	$51.05M	-$4.71M
2012-09-30	Reported	(m)	-$10.49M	(m)	(m)	(m)	$15.01M*	$14.21M*	(m)	$66.21M	$46.34M	-$6.40M
2012-06-30	Reported	(m)	-$30.95M	(m)	(m)	(m)	$9.48M*	-$1.42M*	(m)	$77.81M	$51.54M	-$411.00K
2012-03-31	Reported	(m)	-$21.87M	(m)	(m)	(m)	$6.18M	-$7.17M	(m)	$73.83M	$45.25M	-$34.00K
2011-09-30	Reported	(m)	-$15.52M	(m)	(m)	(m)	$56.39M*	$8.86M*	(m)	$58.58M	$44.88M	-$2.08M
2011-06-30	Reported	(m)	$768.00K	(m)	(m)	(m)	$1.91M*	$13.57M*	(m)	$52.91M	$41.02M	$3.90M
2011-03-31	Reported	(m)	$2.29M	(m)	(m)	(m)	$6.24M	-$3.50M	(m)	$45.02M	$41.04M	$4.76M
2010-09-30	Reported	(m)	-$1.94M	(m)	(m)	(m)	$9.37M*	$9.06M*	(m)	$39.37M	$38.35M	-$221.95M
2010-06-30	Reported	(m)	$3.04M	(m)	(m)	(m)	$15.24M*	$22.22M*	(m)	$35.65M	$37.28M	$1.06M
2010-03-31	Reported	(m)	$2.79M	(m)	(m)	(m)	$14.11M	$3.25M	(m)	$30.10M	$34.00M	$636.00K
2009-09-30	Reported	(m)	$10.13M	(m)	(m)	(m)	$26.56M*	$28.43M*	(m)	$26.99M	$28.67M	$945.00K
2009-06-30	Reported	(m)	$4.31M	(m)	(m)	(m)	(m)	(m)	(m)	$26.32M	$30.53M	$522.00K

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	$489.04M	(m)	(m)	(m)	15.18%	$103.04M	$827.99M	(m)	$921.93M	$1.15B	$133.58M
2024-12-31	Reported	$580.64M	(m)	(m)	(m)	20.35%	$85.42M	$572.84M	(m)	$747.18M	$1.01B	$114.90M
2023-12-31	Reported	$290.16M	(m)	(m)	(m)	11.99%	$96.69M	$159.26M	(m)	$746.77M	$892.41M	$20.92M
2022-12-31	Reported	$262.94M	(m)	(m)	(m)	12.54%	$120.96M	$175.90M	(m)	$649.61M	$823.24M	$8.02M
2021-12-31	Reported	$25.7M	(m)	(m)	(m)	1.39%	$95.58M	$304.54M	(m)	$628.79M	$759.38M	-$11.27M
2020-12-31	Reported	$61.73M	(m)	(m)	(m)	3.32%	$114.31M	$85.36M	(m)	$628.12M	$737.67M	-$903.03M
2019-12-31	Reported	$4.84M	(m)	(m)	(m)	0.28%	$145.03M	$48.26M	(m)	$715.01M	$680.92M	-$70.96M
2018-12-31	Reported	-$27.85M	(m)	(m)	(m)	-1.87%	$144.62M	$20.21M	(m)	$696.33M	$604.35M	-$65.49M
2017-12-31	Reported	$73.16M	(m)	(m)	(m)	5.57%	$199.22M	-$8.76M	(m)	$610.75M	$554.34M	$81.17M
2016-12-31	Reported	-$706.52M	(m)	(m)	(m)	-63.26%	$148.38M	-$227.84M	(m)	$661.90M	$476.59M	-$200.84M
2015-12-31	Reported	-$63.52M	(m)	(m)	(m)	-7.14%	$227.65M	(m)	(m)	$634.81M	$402.27M	$17.07M
2014-12-31	Reported	-$47.02M	(m)	(m)	(m)	-6.28%	$117.06M	(m)	(m)	$461.54M	$302.16M	$9.10M
2013-12-31	Reported	-$119.99M	(m)	(m)	(m)	-21.88%	$65.19M	-$59.63M	(m)	$354.78M	$235.36M	-$150.00K
2012-12-31	Reported	(m)	-$110.22M	(m)	(m)	(m)	$44.57M	$17.61M	(m)	$302.22M	$198.17M	-$3.93M
2011-12-31	Reported	(m)	-$33.89M	(m)	(m)	(m)	$73.22M	$18.41M	(m)	$214.37M	$175.42M	$10.21M
2010-12-31	Reported	(m)	$544.00K	(m)	(m)	(m)	$49.46M	$18.75M	(m)	$147.31M	$151.72M	-$227.31M
2009-12-31	Reported	(m)	$16.43M	(m)	(m)	(m)	$89.80M	$87.73M	(m)	$115.12M	$124.29M	$1.05M
2008-12-31	Reported	(m)	$39.76M	(m)	(m)	(m)	$56.37M	-$9.18M	(m)	$93.29M	$106.57M	$2.59M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
MADRIGAL PHARMACEUTICALS, INC. (MDGL)	United States	$11.859B	-38.17
Elanco Animal Health Inc (ELAN)	United States	$11.177B	-61.80
CORCEPT THERAPEUTICS INC (CORT)	United States	$12.804B	169.10
BridgeBio Pharma, Inc. (BBIO)	United States	$12.947B	-20.72
Summit Therapeutics Inc. (SMMT)	United States	$13.071B	-13.21
Axsome Therapeutics, Inc. (AXSM)	United States	$10.274B	-66.82
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)	United States	$9.331B	-42.28
CYTOKINETICS INC (CYTK)	United States	$9.130B	-11.86
Protagonist Therapeutics, Inc (PTGX)	United States	$8.883B	95.52
TG THERAPEUTICS, INC. (TGTX)	United States	$8.805B	19.05